Glioblastoma (GBM) is a rare and aggressive form of brain cancer with a devastating prognosis. Because GBM can cause severe cognitive deficits, it can make overwhelmed patients even more confused. Optune is a wearable, portable device that uses electric fields to destroy cancer cells. While it’s a highly innovative treatment, it’s also a highly unknown type of treatment. Our goal was to create a website that educates patients and care partners on Optune technology while understanding the unique cognitive challenges of those interacting with our website. Upon arriving on Optune.com, patients can choose from “Recently diagnosed,” “Starting Optune,” or “Currently using Optune.” After making that selection, patients will find content specifically curated for their needs. We also ensured that the: • Content is written at a 3rd grade reading level, with short, simple language • Tone is approachable, warm, and supportive • Graphics and patient imagery are used heavily to help visualize content • Downloadable resources and videos are purposely placed throughout the site Since launching on February 1st, 2023, we have seen exceptional results: • Sign up completion for Buddy Calls exceeded expectations with an increase of more than 300% • 70% engagement rate of the entire site, surpassing industry benchmarks • Registrations for webinars have increased 80x These metrics were compared against the last site iteration. NOTE: As of November 2023, Optune is now known as Optune Gio. This submission reflects the past site prior to a website redesign.
Contributors:
Sr. Product Manager, GBM Patient Marketing Novocure: | Kyle Chan |
Chief Creative Officer, Patients & Purpose: | Dina Peck |
Associate Partner, Group Creative Director, Patients & Purpose: | Tom Galati |
SVP, Managing Director: | Jennifer Ohlberg |
SVP, Creative Director, Art: | Nora Travis |
SVP, Creative Director, Copy: | Ilyssa Berger Wilson |
VP, Group Art Supervisor: | Michelle Leone |
VP, Group Copy Supervisor : | Michaela Berkon |
Copy Supervisor: | Katie Bahr |
Art Supervisor: | Tatyana Petra |
PATIENTS & PURPOSE
Location: United States